Acro Biomedical Co., Ltd. (ACBM)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue 658.5 Thousand 1.19 Million 687.96 Thousand 193.53 Thousand 8.01 Million 510 Thousand
Cost of Revenue 518 Thousand 938 Thousand 528.56 Thousand 181.44 Thousand 7.18 Million 459 Thousand
Gross Profit 140.5 Thousand 259.5 Thousand 159.4 Thousand 12.09 Thousand 833.4 Thousand 51 Thousand
Operating Expenses 16.01 Million 7.95 Million 289.86 Thousand 434.84 Thousand 317.85 Thousand 53.24 Thousand
Selling, General and Administrative Expenses 5.93 Million 2.66 Million 289.86 Thousand 434.84 Thousand 317.85 Thousand 53.24 Thousand
Research and Development Expenses 10.08 Million 5.28 Million - - - -
Other Expenses - - - - - 52.38 Thousand
Cost and Expenses 16.52 Million 8.89 Million 818.42 Thousand 616.28 Thousand 7.49 Million 512.24 Thousand
Operating Income -15.86 Million -7.69 Million -130.46 Thousand -422.75 Thousand 515.55 Thousand -2248.00
Interest Expense 1706.00 4250.00 5082.00 1983.00 3663.00 -
Income Tax Expense - 4250.00 -18.09 Thousand -53.13 Thousand 92.22 Thousand -2246.00
Earnings before Tax -15.87 Million -7.69 Million -135.54 Thousand -424.73 Thousand 511.88 Thousand -2248.00
Net Income -15.87 Million -7.7 Million -117.45 Thousand -371.6 Thousand 419.66 Thousand -2248.00
Earnings Per Share Basic -0.26 -0.14 -0.00 -0.01 0.01 -
Earnings Per Share Diluted -0.26 -0.14 -0.00 -0.01 0.01 -
Weighted Average Shares Outstanding 60.04 Million 53.83 Million 47.76 Million 47.76 Million 47.66 Million 47.17 Million
Weighted Average Shares Outstanding (Diluted) 60.04 Million 53.83 Million 47.76 Million 47.76 Million 47.66 Million 47.17 Million
Gross Margin 0.21 0.22 0.23 0.06 0.10 0.10
EBIT Margin -24.10 -6.42 -0.19 -2.18 0.06 -0.00
Profit Margin -24.10 -6.43 -0.17 -1.92 0.05 -0.00
EBITDA -15.86 Million -7.69 Million -130.46 Thousand -301.73 Thousand 515.55 Thousand -2248.00
Earnings Before Tax Margin -24.10 -6.42 -0.19 -2.18 0.06 -0.00

Income Statement Charts